Wockhardt gets US nod for Alzheimer`s drug

Published on Thu, Jan 07, 2010 at 08:59 |  Source : Reuters

Updated at Thu, Jan 07, 2010 at 11:02  

12145 Investors following Wockhardt. Share this News with them.
0
0
Share on Tumblr
Wockhardt gets US nod for Alzheimer`s drug

RELATED NEWS

Indian drug maker Wockhardt Ltd said on Wednesday the US Food and Drug Administration tentatively approved the sale of its generic memantine HCL, which is used to treat Alzheimer's and dementia.

The approval is for 5-milligram and 10-mg tablets of the drug, which is the generic version of Forest Laboratories' Namenda.

  

More on Moneycontrol

Trending News

Business News

Android phones to capture 80 percent of Indian market by 2015
How the Reliance gas choke will cause a huge loss to India "How the Reliance gas choke will cause a huge loss to India"

Sources On KFA CNBC-TV18 Exclusive No Meeting Scheduled For This Week

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 21 2012, 14:24

Rally to continue, market may see new high: Punita Sinha

- in MARKET OUTLOOK

Feb 21 2012, 14:24

Alfa Laval delisting offer: What should an investor do?

- in MARKET OUTLOOK

Interviews

Feb 21 2012, 15:00 | Source: CNBC-TV18

'Left Bajaj Electronics to pursue personal goals'  

Feb 21 2012, 14:19 | Source: CNBC-TV18

Estimate interest rate for bond issue at 7.95-8.10%: REC  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com